Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Lam Research Corp a un objectif de cours consensuel de 567,61 $ basé sur les notes de 38 analystes. Le plus haut est de 1 350 $ émis par HSBC le 10 mai 2024<. Le plus bas est de 100 $ émis par Deutsche Bank le 5 août 2024. Les 3 dernières notations d'analystes ont été publiées par New Street Research, Goldman Sachs et Deutsche Bank respectivement le 6 août 2024, le 5 août 2024 et le 5 août 2024. Avec un objectif de cours moyen de 118,33 $ entre New Street Research, Goldman Sachs et Deutsche Bank, il existe une hausse implicite de 0,21 % pour Lam Research Corp à partir de ces notations d'analystes les plus récentes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/23/2025 | — | UBS | $155 → $165 | Maintains | Buy | |||
10/23/2025 | — | JP Morgan | $113 → $165 | Maintains | Overweight | |||
10/23/2025 | — | Susquehanna | $135 → $200 | Maintains | Positive | |||
10/23/2025 | — | B. Riley Securities | $175 → $180 | Maintains | Buy | |||
10/23/2025 | — | TD Cowen | $145 → $170 | Maintains | Buy | |||
10/23/2025 | — | Stifel | $135 → $160 | Maintains | Buy | |||
10/23/2025 | — | Wells Fargo | $135 → $145 | Maintains | Equal-Weight | |||
10/23/2025 | — | Oppenheimer | $120 → $200 | Maintains | Outperform | |||
10/23/2025 | — | Mizuho | $162 → $170 | Maintains | Outperform | |||
10/23/2025 | — | Morgan Stanley | $125 → $137 | Maintains | Equal-Weight | |||
10/23/2025 | — | Citigroup | $120 → $175 | Maintains | Buy | |||
10/23/2025 | — | Needham | $150 → $160 | Maintains | Buy | |||
10/20/2025 | — | Barclays | $83 → $142 | Maintains | Equal-Weight | |||
10/16/2025 | — | Mizuho | $130 → $162 | Maintains | Outperform | |||
10/13/2025 | — | Stifel | $115 → $135 | Maintains | Buy | |||
10/09/2025 | — | Goldman Sachs | $115 → $160 | Maintains | Buy | |||
09/30/2025 | — | HSBC | → $127 | Initiates | → Hold | |||
09/29/2025 | — | Deutsche Bank | $100 → $150 | Upgrade | Hold → Buy | |||
09/24/2025 | — | B. Riley Securities | $130 → $160 | Maintains | Buy | |||
09/23/2025 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
09/22/2025 | — | Morgan Stanley | $92 → $125 | Upgrade | Underweight → Equal-Weight | |||
09/12/2025 | — | Mizuho | $120 → $130 | Maintains | Outperform | |||
09/08/2025 | — | Citigroup | $113 → $120 | Maintains | Buy | |||
09/02/2025 | — | Morgan Stanley | $94 → $92 | Downgrade | Equal-Weight → Underweight | |||
08/21/2025 | — | Cantor Fitzgerald | $115 → $120 | Maintains | Overweight | |||
08/01/2025 | — | Citigroup | $108 → $113 | Maintains | Buy | |||
08/01/2025 | — | Argus Research | $105 → $120 | Maintains | Buy | |||
08/01/2025 | — | Mizuho | $115 → $120 | Maintains | Outperform | |||
07/31/2025 | — | Wells Fargo | $95 → $98 | Maintains | Equal-Weight | |||
07/31/2025 | — | Stifel | $110 → $115 | Maintains | Buy | |||
07/31/2025 | — | Morgan Stanley | $87 → $94 | Maintains | Equal-Weight | |||
07/31/2025 | — | Raymond James | $90 → $110 | Maintains | Outperform | |||
07/31/2025 | — | Oppenheimer | $110 → $120 | Maintains | Outperform | |||
07/31/2025 | — | Needham | $110 → $115 | Maintains | Buy | |||
07/29/2025 | — | Stifel | $92 → $110 | Maintains | Buy | |||
07/28/2025 | — | Barclays | $70 → $83 | Maintains | Equal-Weight | |||
07/21/2025 | — | UBS | $95 → $120 | Maintains | Buy | |||
07/15/2025 | — | Keybanc | $105 → $115 | Maintains | Overweight | |||
07/14/2025 | — | Mizuho | $100 → $115 | Maintains | Outperform | |||
07/10/2025 | — | Goldman Sachs | → $115 | Initiates | → Buy | |||
07/08/2025 | — | Wells Fargo | $75 → $95 | Maintains | Equal-Weight | |||
07/07/2025 | — | Citigroup | $87 → $108 | Maintains | Buy | |||
07/01/2025 | — | Morgan Stanley | $82 → $87 | Maintains | Equal-Weight | |||
06/24/2025 | — | Cantor Fitzgerald | $90 → $115 | Maintains | Overweight | |||
06/18/2025 | — | B. Riley Securities | $95 → $115 | Maintains | Buy | |||
06/17/2025 | — | Oppenheimer | $80 → $110 | Maintains | Outperform | |||
04/24/2025 | — | UBS | $90 → $95 | Maintains | Buy | |||
04/24/2025 | — | JP Morgan | $110 → $95 | Maintains | Overweight | |||
04/24/2025 | — | Raymond James | $100 → $90 | Maintains | Outperform | |||
04/24/2025 | — | Deutsche Bank | $78 → $70 | Maintains | Hold | |||
04/24/2025 | — | B. Riley Securities | $90 → $95 | Maintains | Buy | |||
04/24/2025 | — | Needham | $96 → $80 | Maintains | Buy | |||
04/24/2025 | — | Morgan Stanley | $81 → $82 | Maintains | Equal-Weight | |||
04/24/2025 | — | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
04/24/2025 | — | TD Securities | $110 → $100 | Maintains | Buy | |||
04/24/2025 | — | Wells Fargo | $85 → $75 | Maintains | Equal-Weight | |||
04/24/2025 | — | Evercore ISI Group | $95 → $99 | Maintains | Outperform | |||
04/22/2025 | — | Barclays | $75 → $70 | Maintains | Equal-Weight | |||
04/16/2025 | — | B of A Securities | $110 → $90 | Maintains | Buy | |||
04/15/2025 | — | Stifel | $100 → $92 | Maintains | Buy | |||
04/14/2025 | — | UBS | $95 → $90 | Maintains | Buy | |||
04/11/2025 | — | Oppenheimer | $95 → $80 | Maintains | Outperform | |||
03/28/2025 | — | Jefferies | $95 → $100 | Maintains | Buy | |||
03/20/2025 | — | Oppenheimer | → $95 | Initiates | → Outperform | |||
02/20/2025 | — | Keybanc | $95 → $105 | Maintains | Overweight | |||
02/20/2025 | — | B of A Securities | $100 → $110 | Maintains | Buy | |||
02/20/2025 | — | Susquehanna | $75 → $125 | Upgrade | Neutral → Positive | |||
02/20/2025 | — | Mizuho | $87 → $100 | Maintains | Outperform | |||
02/20/2025 | — | Cantor Fitzgerald | $100 → $100 | Reiterates | Overweight → Overweight | |||
02/18/2025 | — | Cantor Fitzgerald | $100 → $100 | Maintains | Overweight | |||
01/31/2025 | — | Deutsche Bank | $76 → $78 | Maintains | Hold | |||
01/30/2025 | — | Morgan Stanley | $78 → $81 | Maintains | Equal-Weight | |||
01/30/2025 | — | Mizuho | $90 → $87 | Maintains | Outperform | |||
01/30/2025 | — | Cantor Fitzgerald | $95 → $100 | Upgrade | Neutral → Overweight | |||
01/30/2025 | — | Wells Fargo | $82 → $85 | Maintains | Equal-Weight | |||
01/30/2025 | — | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
01/17/2025 | — | Keybanc | $95 → $95 | Upgrade | Sector Weight → Overweight | |||
01/17/2025 | — | Barclays | $90 → $75 | Maintains | Equal-Weight | |||
01/15/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
01/13/2025 | — | Needham | $100 → $90 | Maintains | Buy | |||
01/13/2025 | — | Wells Fargo | $83 → $82 | Maintains | Equal-Weight | |||
01/10/2025 | — | Mizuho | $95 → $90 | Maintains | Outperform | |||
01/10/2025 | — | Goldman Sachs | $96 → $85 | Maintains | Buy | |||
12/06/2024 | — | Wells Fargo | $85 → $83 | Maintains | Equal-Weight | |||
12/05/2024 | — | Morgan Stanley | $76 → $78 | Maintains | Equal-Weight | |||
11/29/2024 | — | Bernstein | $95 → $85 | Maintains | Market Perform | |||
10/24/2024 | — | Cantor Fitzgerald | $100 → $100 | Reiterates | Neutral → Neutral | |||
10/24/2024 | — | Morgan Stanley | $77 → $76 | Maintains | Equal-Weight | |||
10/24/2024 | — | Stifel | $105 → $100 | Reiterates | Buy → Buy | |||
10/24/2024 | — | Wells Fargo | $88 → $85 | Maintains | Equal-Weight | |||
10/24/2024 | — | B. Riley Securities | $105 → $110 | Reiterates | Buy → Buy | |||
10/24/2024 | — | Needham | $100 → $100 | Reiterates | Buy → Buy | |||
10/03/2024 | — | Wells Fargo | $1000 → $880 | Maintains | Equal-Weight | |||
09/30/2024 | — | Cantor Fitzgerald | $1200 → $1000 | Maintains | Neutral | |||
09/20/2024 | — | Mizuho | $1050 → $950 | Maintains | Outperform | |||
09/17/2024 | — | Morgan Stanley | $929 → $774 | Maintains | Equal-Weight | |||
09/16/2024 | — | Citigroup | $990 → $893 | Maintains | Buy | |||
09/12/2024 | — | UBS | $1250 → $1150 | Maintains | Buy | |||
08/05/2024 | — | Citigroup | $1025 → $990 | Maintains | Buy | |||
08/01/2024 | — | Mizuho | $960 → $1050 | Maintains | Outperform |
Le dernier objectif de prix pour Lam Research (NASDAQ:LRCX) a été rapporté par UBS le octobre 23, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $165.00 s'attendant à ce que LRCX se rise dans les 12 prochains mois (un possible changement de 5.67% upside). 86 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Lam Research (NASDAQ:LRCX) a été fournie par UBS, et Lam Research maintenu leur note buy.
La dernière amélioration pour Lam Research Corp a eu lieu le septembre 29, 2025 lorsque Deutsche Bank a augmenté leur objectif de prix à $150. Deutsche Bank avait précédemment a hold pour Lam Research Corp.
La dernière réduction pour Lam Research Corp a eu lieu le septembre 23, 2025 lorsque Keybanc a changé leur objectif de prix de N/A à N/A pour Lam Research Corp.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Lam Research, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Lam Research a été déposée le octobre 23, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 23, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Lam Research (LRCX) était un maintenu avec un objectif de prix de $155.00 à $165.00. Le prix actuel de Lam Research (LRCX) est de $156.15, ce qui est within la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.